Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (49)
Ana Teresa Timóteo, Regina Ribeiras, Rita Calé, Brenda Moura, Ana G. Almeida, Cristina Gavina, Sofia Cabral, Natália António, Fátima Franco, Rita Ilhão Moreira, Fernanda Geraldes, Ana Paula Machado, Fátima Palma, Vera Pires da Silva & Lino Gonçalves. (2023) Saúde cardiovascular da mulher – Documento de Consenso da Sociedade Portuguesa de Cardiologia, Sociedade Portuguesa de Ginecologia, Sociedade Portuguesa de Obstetrícia e Medicina Materno‐Fetal, Sociedade Portuguesa de Contraceção e Associação Portuguesa de Medicina Geral e Familiar. Revista Portuguesa de Cardiologia 42:12, pages 1001-1015.
Crossref
Crossref
Mercedes Millán-de-Meer, Manuel Luque-Ramírez, Lía Nattero-Chávez & Héctor F Escobar-Morreale. (2023) PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis. Human Reproduction Update 29:6, pages 741-772.
Crossref
Crossref
Angelica Lindén Hirschberg. (2023) Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
Xiao Zhang, Zhao Huangfu & Shaowei Wang. (2023) No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study. Endocrine 82:3, pages 695-706.
Crossref
Crossref
Nibu Dominic, Lokesh Sharma, Namita Mohindra & Preeti Dabadghao. (2023) Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India. Endocrine.
Crossref
Crossref
Kim van der Ham, Maria P. H. Koster, Birgitta K. Velthuis, Ricardo P. J. Budde, Bart C. J. M. Fauser, Joop S. E. Laven & Yvonne V. Louwers. (2023) Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome. Journal of Clinical Medicine 12:16, pages 5226.
Crossref
Crossref
Alok Kumar Dwivedi, Deepanjali Vishwakarma, Pallavi Dubey & Sireesha Reddy. (2023) Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States. European Journal of Endocrinology 188:6, pages 555-563.
Crossref
Crossref
Walter Masson, Leandro Barbagelata, Martín Lobo, Augusto Lavalle-Cobo, Pablo Corral & Juan Patricio Nogueira. (2023) Plasma Lipoprotein(a) Levels in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. High Blood Pressure & Cardiovascular Prevention 30:4, pages 305-317.
Crossref
Crossref
M. Farhadi-Azar, M. Noroozzadeh, M. Ghahremani, M. Rahmati, M. Saei Ghare Naz, F. Azizi & F. Ramezani Tehrani. (2023) Maternal androgen excess increases the risk of pre-diabetes mellitus in male offspring in later life: a long-term population-based follow-up study. Journal of Endocrinological Investigation 46:9, pages 1775-1785.
Crossref
Crossref
Mohadetheh Moulana. (2023) Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes. Life 13:4, pages 1010.
Crossref
Crossref
Mugdha Jungari, Amruta Choudhary & Naresh Kumar Gill. (2023) Comprehensive Management of Polycystic Ovary Syndrome: Effect of Pharmacotherapy, Lifestyle Modification, and Enhanced Adherence Counseling. Cureus.
Crossref
Crossref
Leila Mahmoudieh, Mina Amiri, Maryam Rahmati, Ali Siamak Habibi Moeini, Farzaneh Sarvghadi, Fereidoun Azizi & Fahimeh Ramezani Tehrani. (2023) Idiopathic Hirsutism and Metabolic Status: A Population-based Prospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism 108:1, pages 114-123.
Crossref
Crossref
Angela K. Lucas-Herald & Rhian M. Touyz. (2022) Androgens and Androgen Receptors as Determinants of Vascular Sex Differences Across the Lifespan. Canadian Journal of Cardiology 38:12, pages 1854-1864.
Crossref
Crossref
Kellsey A. Peterson, Gurleen Kaur, Eugenia Gianos, Sulagna Mookherjee, Kim A. Poli, Mandeep S. Sidhu & Radmila Lyubarova. (2021) Challenges in Optimizing Lipid Management in Women. Cardiovascular Drugs and Therapy 36:6, pages 1197-1220.
Crossref
Crossref
Li Li, Jianxiu Yu & Zhongwei Zhou. (2022) Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: A PRISMA-compliant systematic review and meta-analysis. Medicine 101:38, pages e30579.
Crossref
Crossref
Garima Kachhawa, Krithika V. Senthil Kumar, Vidushi Kulshrestha, Rajesh Khadgawat, Reeta Mahey & Neerja Bhatla. (2021)
Efficacy of myo‐inositol and
d
‐chiro‐inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open‐label study
. International Journal of Gynecology & Obstetrics 158:2, pages 278-284.
Crossref
Crossref
Eleni A. Kandaraki & Olga Papalou. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
80
91
.
Rossella E Nappi, Peter Chedraui, Irene Lambrinoudaki & Tommaso Simoncini. (2022) Menopause: a cardiometabolic transition. The Lancet Diabetes & Endocrinology 10:6, pages 442-456.
Crossref
Crossref
Congying Wang, Wei Wu, Haiyan Yang, Zhenhong Ye, Yue Zhao, Jun Liu & Liangshan Mu. (2022) Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges. Trends in Genetics 38:5, pages 468-482.
Crossref
Crossref
Joanne Michelle D. Gomez, Katherine VanHise, Nina Stachenfeld, Jessica L. Chan, Noel Bairey Merz & Chrisandra Shufelt. (2022) Subclinical cardiovascular disease and polycystic ovary syndrome. Fertility and Sterility 117:5, pages 912-923.
Crossref
Crossref
Pomme I. H. G. Simons, Merel E. B. Cornelissen, Olivier Valkenburg, N. Charlotte Onland‐Moret, Yvonne T. van der Schouw, Coen D.A. Stehouwer, Stephen Burgess & Martijn C. G. J. Brouwers. (2021) Causal relationship between polycystic ovary syndrome and coronary artery disease: A Mendelian randomisation study. Clinical Endocrinology 96:4, pages 599-604.
Crossref
Crossref
Fatemeh Mahboobifard, Maryam Rahmati, Atrin Niknam, Ehsan Rojhani, Amir Abbas Momenan, Fereidoun Azizi & Fahimeh Ramezani Tehrani. (2022) Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study. Archives of Medical Research 53:3, pages 312-322.
Crossref
Crossref
Enrico Carmina. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
217
224
.
Eleni Armeni & Irene Lambrinoudaki. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
245
285
.
Nika Aleksandra Kravos, Andrej Janež, Katja Goričar, Vita Dolžan & Mojca Jensterle. (2021) Effects of metformin withdrawal after long and short term treatment in PCOS: observational longitudinal study. Diabetology & Metabolic Syndrome 13:1.
Crossref
Crossref
Fahimeh Ramezani Tehrani, Maryam Rahmati, Fatemeh Mahboobifard, Faezeh Firouzi, Nazanin Hashemi & Fereidoun Azizi. (2021) Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome. Reproductive Biology and Endocrinology 19:1.
Crossref
Crossref
Licy L. Yanes Cardozo & Damian G. Romero. (2021) Management of cardiometabolic complications in polycystic ovary syndrome: Unmet needs. The FASEB Journal 35:11.
Crossref
Crossref
Lowri A. Allen, Natasha Shrikrishnapalasuriyar & Dafydd Aled Rees. (2021) Long‐term health outcomes in young women with polycystic ovary syndrome: A narrative review. Clinical Endocrinology.
Crossref
Crossref
Srdan Pandurevic, Djuro Macut, Flaminia Fanelli, Uberto Pagotto & Alessandra Gambineri. (2021) Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk. Biomolecules 11:9, pages 1350.
Crossref
Crossref
Styliani A. Geronikolou, Athanasia Pavlopoulou, Dennis V. Cokkinos, Flora Bacopoulou & George P. Chrousos. (2021) Polycystic οvary syndrome revisited: An interactions network approach. European Journal of Clinical Investigation 51:9.
Crossref
Crossref
Thomas R Berni, Christopher L Morgan & D Aled Rees. (2021) Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study. The Journal of Clinical Endocrinology & Metabolism 106:9, pages e3369-e3380.
Crossref
Crossref
Damian G Romero & Licy L Yanes Cardozo. (2021) Cardiovascular Events in Polycystic Ovary Syndrome: Is the Debate Settled for Good?. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
Deaglan McCullough, Richard Webb, Kevin J. Enright, Katie E. Lane, Jim McVeigh, Claire E. Stewart & Ian G. Davies. (2020) How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health. Reviews in Endocrine and Metabolic Disorders 22:2, pages 389-405.
Crossref
Crossref
Maryam Kazemi, Joy Y. Kim, Stephen A. Parry, Ricardo Azziz & Marla E. Lujan. (2021) Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 224:5, pages 428-444.e8.
Crossref
Crossref
Kathleen M Hoeger, Anuja Dokras & Terhi Piltonen. (2021) Update on PCOS: Consequences, Challenges, and Guiding Treatment. The Journal of Clinical Endocrinology & Metabolism 106:3, pages e1071-e1083.
Crossref
Crossref
Angela H E M Maas, Giuseppe Rosano, Renata Cifkova, Alaide Chieffo, Dorenda van Dijken, Haitham Hamoda, Vijay Kunadian, Ellen Laan, Irene Lambrinoudaki, Kate Maclaran, Nick Panay, John C Stevenson, Mick van Trotsenburg & Peter Collins. (2021) Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. European Heart Journal 42:10, pages 967-984.
Crossref
Crossref
Marit L. Bovbjerg. (2021) Current Resources for Evidence-Based Practice, March 2021. Journal of Obstetric, Gynecologic & Neonatal Nursing 50:2, pages 225-236.
Crossref
Crossref
Laura G. Cooney & Anuja Dokras. (2021) Cardiometabolic Risk in Polycystic Ovary Syndrome. Endocrinology and Metabolism Clinics of North America 50:1, pages 83-95.
Crossref
Crossref
Linda G Kahn, Kim G Harley, Eva L Siegel, Yeyi Zhu, Pam Factor-Litvak, Christina A Porucznik, Michele Klein-Fedyshin & Alison E Hipwell. (2021) Persistent organic pollutants and couple fecundability: a systematic review. Human Reproduction Update 27:2, pages 339-366.
Crossref
Crossref
Tiantian Zhu, Jinrui Cui & Mark O. Goodarzi. (2021) Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke. Diabetes 70:2, pages 627-637.
Crossref
Crossref
Julia K. Bosdou, Panagiotis Anagnostis, George T. Lainas & Efstratios M. Kolibianakis. (2020) Female Infertility and Cardiovascular Risk - A Hype or an Underestimated Reality?. Current Pharmaceutical Design 26:43, pages 5551-5555.
Crossref
Crossref
Mina Amiri, Fahimeh Ramezani Tehrani, Samira Behboudi-Gandevani, Razieh Bidhendi-Yarandi & Enrico Carmina. (2020) Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reproductive Biology and Endocrinology 18:1.
Crossref
Crossref
Mahsa Noroozzadeh, Mohammad Reza Raoufy, Razieh Bidhendi Yarandi, Farzaneh Faraji Shahrivar, Naghmeh Moghimi & Fahimeh Ramezani Tehrani. (2020) Cardiac function and tolerance to ischemia/reperfusion injury in a rat model of polycystic ovary syndrome during the postmenopausal period. Life Sciences 262, pages 118394.
Crossref
Crossref
Samira Behboudi‐Gandevani, Mina Amiri, Leila Cheraghi, Saber Amanollahi Soudmand, Fereidoun Azizi & Fahimeh Ramezani Tehrani. (2020) The risk of chronic kidney disease among women with polycystic ovary syndrome: A long‐term population‐based cohort study. Clinical Endocrinology 93:5, pages 590-597.
Crossref
Crossref
Cheng-Hsuan Wu, Lu-Ting Chiu, Yu-Jun Chang, Chun-I Lee, Maw-Sheng Lee, Tsung-Hsien Lee & James Cheng-Chung Wei. (2020) Hypertension Risk in Young Women With Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study. Frontiers in Medicine 7.
Crossref
Crossref
Noha M. Shawky, Chetan N. PatilCarolina DalmassoRodrigo O. MaranonDamian G. Romero, Heather Drummond & Jane F. Reckelhoff. (2020) Pregnancy Protects Hyperandrogenemic Female Rats From Postmenopausal Hypertension. Hypertension 76:3, pages 943-952.
Crossref
Crossref
Nafiye Helvaci & Bulent Okan Yildiz. (2020) Polycystic ovary syndrome and aging: Health implications after menopause. Maturitas 139, pages 12-19.
Crossref
Crossref
Meeta Meeta, Leela Digumarti, Neelam Agarwal, Nirmala Vaze, Rashmi Shah & Sonia Malik. (2020) Clinical practice guidelines on menopause: *An executive summary and recommendations: Indian menopause society 2019–2020. Journal of Mid-life Health 11:2, pages 55.
Crossref
Crossref
Edgar D Torres Fernandez, Alexandra M Huffman, Maryam Syed, Damian G Romero & Licy L Yanes Cardozo. (2019) Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS. Endocrinology 160:12, pages 2787-2799.
Crossref
Crossref